2 FTSE shares I’m already eyeing for August

Our writer has been considering some possible purchases for his portfolio in the month of August. These two names caught his eye.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

pensive bearded business man sitting on chair looking out of the window

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

After a hot July for some stocks, my focus is already starting to move towards August. Here are a couple of FTSE shares I am considering adding to my portfolio during the month.

Assura

Healthcare property landlord Assura (LSE: AGR) has several things going for it as far as I can see.

The long-term demand for healthcare is likely to be resilient, which means lots of buildings such as GP surgeries and ambulance depots are still needed. The sorts of tenants that rent those premises often do so for decades on end and can be relied upon to pay their bills. That compares favourably to the scrappier end of the commercial property market.

That helps Assura to generate substantial and fairly predictable cash flows, which in turn can fund dividends. At the moment, the dividend yield on offer is 4.4%. I think that is attractive. I also like the group’s valuation. Its price-to-earnings ratio of 12 looks like fair value to me for a quality business.

What could happen to change my analysis? One risk I see is the political risk of price capping for service providers to the NHS. Even without that, the politically sensitive nature of the sector could limit the profits to be made. But Assura’s large and growing estate looks set to be a long-term money spinner to me. That is why I would consider adding the shares to my portfolio.

Dunelm

Like Assura, Dunelm (LSE: DNLM) is a member of the FTSE 250 index. But unlike Assura, its name is known to millions of people as it has a nationwide chain of homeware stores.

Is now a good time to be in homewares, given the risk that consumer belt tightening could mean less money is spent on home decoration? Obviously some investors are sceptical. That risk helps explain why the shares have plummeted 35% over the past year.

But I think a recession may actually turn out to help sales at Dunelm. It stocks a wide range of items including some at low prices could help it attract new shoppers. Inflation may eat into profit margins, although for now at least the business seems confident it can manage rising prices without hurting profitability.

The shares yield 4%. The dividend is comfortably covered and the company balance sheet looks healthy to me. At the time of its interim results, the company was sitting on net cash of £48m. Free cash flow of £106m in the first half underlined what I see as the attractiveness of Dunelm’s business model. I own the shares in my portfolio and would consider buying more in August.

Buying FTSE shares this summer to hold for years

Both of these FTSE 250 shares strike me as attractive options to add to my portfolio for the long term.

I expect more economic doom and gloom may emerge over the summer, which could offer me an even lower price to buy these two shares. But I already think they offer me attractive long-term value. I like their cash generative business models and would happily buy both.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Christopher Ruane owns shares in Dunelm. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »